Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Equity

PROSHARES TRUST (ZBIO) Return on Capital Employed: 2024-2025

Historic Return on Capital Employed for Zenas BioPharma (ZBIO) over the last 1 years, with Sep 2025 value amounting to -0.79%.

  • Zenas BioPharma's Return on Capital Employed was N/A to -0.79% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.79%, marking a year-over-year change of. This contributed to the annual value of -1.01% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Zenas BioPharma's Return on Capital Employed is -0.79%, which was down 8.23% from -0.73% recorded in Q2 2025.
  • Zenas BioPharma's 5-year Return on Capital Employed high stood at -0.50% for Q4 2024, and its period low was -0.79% during Q3 2025.
  • Moreover, its 2-year median value for Return on Capital Employed was -0.65% (2025), whereas its average is -0.65%.